GSK plc
GLAXOSMITHKLINE is UK based multi-national Pharmaceuticals business and it has a broad portfolio of innovative and established medicines. GSK currently focus on developing new medicines in respiratory, HIV, oncology and immuno-inflammation; with an R&D approach focused on science related to the immune system, use of genetics and advanced technologies. Headquarters is in UK.
In 2021 GSK delivered 1.7 billion medicines, over 767 million vaccines* and 3.7 billion consumer healthcare products.
GSK annual revenue was 29,324 Million GBP and annual net income was 14,956 Million GBP for year ending Dec-2022.
GSK annual revenues for year ending Dec-2021 was 34,144 million GBP and annual operating income was 6,165 million GBP and annual net income of 4,385 million GBP.
GSK had 70,000 employees as on 2022.
As on 2021, GSK has over 90,000 employees across 92 countries and work directly with 37,500 suppliers.